Factorial Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.78M Buy
345,000
+12,000
+4% +$201K 4.19% 4
2025
Q1
$5.12M Buy
333,000
+1,000
+0.3% +$15.4K 3.16% 6
2024
Q4
$7.32M Buy
332,000
+21,000
+7% +$463K 4.2% 1
2024
Q3
$5.6M Buy
311,000
+39,000
+14% +$703K 3.23% 3
2024
Q2
$4.42M Hold
272,000
2.72% 6
2024
Q1
$3.84M Buy
272,000
+29,000
+12% +$409K 2.18% 9
2023
Q4
$2.54M Buy
243,000
+13,000
+6% +$136K 1.61% 24
2023
Q3
$2.35M Buy
230,000
+27,500
+14% +$281K 1.71% 21
2023
Q2
$1.52M Buy
202,500
+48,000
+31% +$361K 1.05% 35
2023
Q1
$1.37M Sell
154,500
-22,000
-12% -$195K 1.03% 35
2022
Q4
$1.61M Buy
176,500
+3,500
+2% +$31.9K 1.23% 32
2022
Q3
$1.4M Buy
173,000
+28,500
+20% +$230K 1.21% 29
2022
Q2
$1.09M Sell
144,500
-6,500
-4% -$48.9K 0.88% 45
2022
Q1
$1.42M Buy
151,000
+63,000
+72% +$592K 0.97% 44
2021
Q4
$705K Sell
88,000
-67,000
-43% -$537K 0.47% 70
2021
Q3
$1.51M Hold
155,000
1.03% 36
2021
Q2
$1.54M Hold
155,000
1.04% 38
2021
Q1
$1.79M Hold
155,000
1.26% 27
2020
Q4
$1.5M Hold
155,000
1.25% 26
2020
Q3
$1.4M Buy
155,000
+2,000
+1% +$18K 1.43% 21
2020
Q2
$1.89M Hold
153,000
2.07% 12
2020
Q1
$1.37M Sell
153,000
-159,000
-51% -$1.43M 1.83% 17
2019
Q4
$2.6M Buy
312,000
+156,000
+100% +$1.3M 1.19% 21
2019
Q3
$1.07M Hold
156,000
1.03% 27
2019
Q2
$1.44M Buy
156,000
+1,000
+0.6% +$9.23K 1.38% 22
2019
Q1
$2.43M Buy
155,000
+6,000
+4% +$94.1K 2.29% 8
2018
Q4
$2.3M Hold
149,000
2.41% 9
2018
Q3
$3.21M Sell
149,000
-4,000
-3% -$86.2K 2.76% 5
2018
Q2
$3.72M Hold
153,000
3.33% 2
2018
Q1
$2.61M Buy
153,000
+6,000
+4% +$103K 2.39% 9
2017
Q4
$2.79M Buy
+147,000
New +$2.79M 2.58% 8